Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,572 | 240,551 | 122,927 | 138,509 | 90,943 |
| Marketable Securities | 29,716 | N/A | N/A | 1,474 | 739 |
| Receivables | 3,799 | 6,348 | 2,629 | 1,646 | N/A |
| Inventories | 2,413 | 77 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 557 | 0 | 0 |
| TOTAL | $165,246 | $252,378 | $131,678 | $146,267 | $94,134 |
| Non-Current Assets | |||||
| PPE Net | 3,843 | 4,236 | 2,499 | 1,945 | 2,265 |
| Other Non-Current Assets | 1,819 | 2,904 | 2,663 | 2,250 | 2,443 |
| TOTAL | $5,662 | $7,140 | $5,162 | $4,195 | $4,708 |
| Total Assets | $170,908 | $259,518 | $136,840 | $150,462 | $98,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,211 | 1,020 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,003 | 4,461 | 3,126 | 2,211 | 2,763 |
| Accrued Expenses | 22,859 | 19,536 | 16,207 | 8,518 | 5,268 |
| Other current liabilities | N/A | N/A | 21,233 | N/A | N/A |
| TOTAL | $40,624 | $25,017 | $40,566 | $10,729 | $8,031 |
| Non-Current Liabilities | |||||
| Long Term Debt | 95,189 | 100,875 | 40,809 | N/A | N/A |
| aiOther Non-Current Liabilities | 18,330 | 17,626 | 1,979 | 2,534 | 3,042 |
| TOTAL | $113,519 | $118,501 | $42,788 | $2,534 | $3,042 |
| Total Liabilities | $154,143 | $143,518 | $83,354 | $13,263 | $11,073 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,643 | 49,665 | 37,003 | 36,578 | 21,678 |
| Common Shares | 55 | 50 | 37 | 37 | 22 |
| Retained earnings | -571,926 | -430,521 | -410,705 | -311,929 | -235,574 |
| Other shareholders' equity | -20 | 4,043 | 4,302 | 4,469 | 28,200 |
| TOTAL | $16,765 | $116,000 | $53,486 | $137,199 | $87,769 |
| Total Liabilities And Equity | $170,908 | $259,518 | $136,840 | $150,462 | $98,842 |